(19)
(11) EP 4 069 261 A2

(12)

(88) Date of publication A3:
15.07.2021

(43) Date of publication:
12.10.2022 Bulletin 2022/41

(21) Application number: 20896972.5

(22) Date of filing: 07.12.2020
(51) International Patent Classification (IPC): 
A61K 35/17(2015.01)
C07K 14/705(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; C12N 2310/3515; C12N 2310/3513; C12N 2310/14; A61P 35/00; C07K 7/06; C07K 7/08; C07K 2319/035
(86) International application number:
PCT/US2020/063676
(87) International publication number:
WO 2021/113851 (10.06.2021 Gazette 2021/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 06.12.2019 US 201962945042 P

(71) Applicant: Sirnaomics, Inc.
Gaithersburg, MD 20879 (US)

(72) Inventors:
  • LU, Xiaoyong
    Gaithersburg, MD 20879 (US)
  • LU, Patrick, Y.
    Gaithersburg, MD 20879 (US)
  • EVANS, David, M.
    Gaithersburg, MD 20879 (US)

(74) Representative: Danner, Stefan 
Danner BioPharm IP Ludwigstraße 8
80539 München
80539 München (DE)

   


(54) PEPTIDE DOCKING VEHICLE FOR TARGETED NUCLEIC ACID DELIVERY